TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/25 17:13 | 10/28/25 | CGEM | Cullinan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 3 | P.m | 13,323 | 7.11 | 0 | 1,874 | 12 | 17,362 | I | ||||||||||||||
10/23/25 19:49 | 10/21/25 | NEUP | Neuphoria Therapeutics Inc. | C3 | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P | 3,283 | 5.14 | 0 | 639 | 271 | 875 | I | ||||||||||||||
9/15/25 20:05 | 9/11/25 | PASG | Passage Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 4 | P.m | 1,483 | 1.50 | 0 | 991 | 6 | 17,570 | I | ||||||||||||||
5/21/25 16:49 | 5/19/25 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 3 | P.m | 3,496 | 1.28 | 0 | 2,722 | 23 | 14,692 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |